To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ANGPTL2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
289 supporting clones for gene ANGPTL2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BM452403 eye, retinoblastoma .a 1 to 546 25 to 571   tiling clone,   547/1153
(47 %)
16 diff
(98.7 %id)
AL598412   .a 106 to 658 1 to 554       554/554
(100 %)
2 diff
(99.7 %id)
AY358274   .a 113 to 2399 1 to 2287 exact     2287/2290
(99 %)
1 diff
(100.0 %id)
AL598400   .a 131 to 773 1 to 643       643/643
(100 %)
1 diff
(99.9 %id)
NM_012098.2   .a 132 to 3703 1 to 3572 exact RefSeq,   3572/3572
(100 %)
0 diff
(100 %id)
BF311106 brain, neuroblastoma .a 147 to 833 1 to 682       682/682
(100 %)
9 diff
(98.7 %id)
AL599049   .a 162 to 631 1 to 470       470/470
(100 %)
1 diff
(99.8 %id)
CD624188   .a 192 to 888 35 to 732       698/732
(95 %)
10 diff
(98.7 %id)
BM007994 Spleen .a 194 to 944 1 to 749       749/749
(100 %)
8 diff
(99.0 %id)
TI_59383405   .a 195 to 944 68 to 815       748/748
(100 %)
8 diff
(99.0 %id)
BI118116 lung, small cell carcinoma .a 209 to 706 1 to 516       513/992
(51 %)
17 diff
(98.3 %id)
AK312876 trachea .a 213 to 2113 1 to 1901 A190G L251P H311L     1901/1901
(100 %)
4 diff
(99.8 %id)
DB235037 trachea .a 214 to 694 2 to 482   capped   481/481
(100 %)
0 diff
(100 %id)
DB290859 uterus .a 214 to 763 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
BX489597   .a 218 to 453 1 to 235       235/235
(100 %)
2 diff
(99.2 %id)
BM906705 ovary (pool of 3) .a 225 to 1219 1 to 999       999/1111
(89 %)
33 diff
(97.1 %id)
AL525307 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 234 to 757 1 to 525       525/892
(58 %)
15 diff
(98.4 %id)
BG819300 anaplastic oligodendroglioma with 1p/19qloss, brain .a 234 to 895 1 to 667       667/667
(100 %)
7 diff
(99.0 %id)
AL527059 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 238 to 1267 1 to 1024   fully sequenced,   1024/1024
(100 %)
29 diff
(97.2 %id)
AL546299 placenta, Placenta Cot 25-normalized .a 238 to 1224 1 to 980       980/1000
(98 %)
14 diff
(98.6 %id)
AU279768   .a 245 to 800 10 to 565       556/556
(100 %)
1 diff
(99.9 %id)
AL547465 placenta, Placenta Cot 25-normalized .a 254 to 1254 1 to 994       994/1001
(99 %)
12 diff
(98.9 %id)
BU149131 sympathetic trunk .a 255 to 1119 1 to 880       880/915
(96 %)
23 diff
(97.5 %id)
BC012368 Ovary, adenocarcinoma .a 259 to 2419 1 to 2161 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 2161/2161
(100 %)
1 diff
(100.0 %id)
BI839002 pooled pancreas and spleen .a 259 to 877 34 to 659       626/659
(94 %)
6 diff
(99.1 %id)
TI_57166150   .a 259 to 877 34 to 659       626/659
(94 %)
6 diff
(99.1 %id)
CF131488 Chondrosarcoma Lung Metastasis cell lines, lung .a 262 to 1057 1 to 797       797/797
(100 %)
1 diff
(99.9 %id)
TI_159677090   .a 262 to 1205 46 to 981       936/1074
(87 %)
21 diff
(98.1 %id)
BP217385 caudate nucleus .a 264 to 863 1 to 599       599/599
(100 %)
4 diff
(99.4 %id)
DB254424 uterus .a 264 to 827 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BF345990 anaplastic oligodendroglioma with 1p/19qloss, brain .a 269 to 1069 1 to 794       794/822
(96 %)
18 diff
(97.9 %id)
TI_57180848   .a 269 to 1008 63 to 804       742/805
(92 %)
9 diff
(98.9 %id)
TI_57163699   .a 269 to 1217 28 to 979       952/981
(97 %)
43 diff
(95.7 %id)
CN390938 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 272 to 944 1 to 673       673/673
(100 %)
1 diff
(99.9 %id)
BI768582 pooled lung and spleen .a 274 to 1008 1 to 737       737/738
(99 %)
5 diff
(99.4 %id)
BI834238 pooled pancreas and spleen .a 274 to 1217 1 to 947       947/949
(99 %)
38 diff
(96.0 %id)
AL554832 placenta, Placenta Cot 25-normalized .a 275 to 1264 1 to 982       982/1017
(96 %)
22 diff
(97.9 %id)
CX756672 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 275 to 1015 1 to 741     Submitted on the opposite strand 741/741
(100 %)
7 diff
(99.1 %id)
CD624193   .a 276 to 922 40 to 691       652/691
(94 %)
10 diff
(98.6 %id)
CD516561 White Matter .a 276 to 1140 1 to 870       870/870
(100 %)
5 diff
(99.5 %id)
BF038016 adenocarcinoma, ovary .a 281 to 981 1 to 695       695/946
(73 %)
24 diff
(97.5 %id)
BG819737 anaplastic oligodendroglioma with 1p/19qloss, brain .a 287 to 1128 1 to 881       881/882
(99 %)
54 diff
(93.9 %id)
CN390941 embryonic stem cells, cell lines H1, H7, andH9 .a 289 to 850 1 to 562       562/562
(100 %)
3 diff
(99.5 %id)
TI_57152932   .a 289 to 1099 25 to 839       815/840
(97 %)
12 diff
(98.6 %id)
BQ879104 dorsal root ganglia .a 290 to 1168 1 to 880       880/881
(99 %)
5 diff
(99.5 %id)
BF038694 adenocarcinoma, ovary .a 293 to 1125 1 to 832       832/941
(88 %)
40 diff
(95.8 %id)
BI765043 pooled colon, kidney, stomach .a 294 to 1099 1 to 811       811/812
(99 %)
9 diff
(98.9 %id)
TI_159676310   .a 298 to 1314 59 to 1075       1017/1143
(88 %)
45 diff
(96.1 %id)
CD624189   .a 306 to 815 37 to 549       513/549
(93 %)
6 diff
(99.0 %id)
CD624191   .a 306 to 949 37 to 677       641/677
(94 %)
8 diff
(98.9 %id)
CD624195   .a 306 to 980 33 to 721       689/721
(95 %)
19 diff
(97.4 %id)
CD624198   .a 306 to 965 33 to 713       681/713
(95 %)
21 diff
(97.1 %id)
BF348335 anaplastic oligodendroglioma with 1p/19qloss, brain .a 311 to 1042 1 to 743       743/819
(90 %)
22 diff
(97.4 %id)
CF131252 Chondrosarcoma Lung Metastasis cell lines, lung .a 338 to 1003 1 to 666       666/666
(100 %)
2 diff
(99.7 %id)
CF132047 Chondrosarcoma Lung Metastasis cell lines, lung .a 433 to 1152 1 to 720       720/720
(100 %)
0 diff
(100 %id)
TI_159677774   .a 433 to 1246 49 to 862       814/1060
(76 %)
2 diff
(99.9 %id)
CN390937 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 462 to 695 1 to 234       234/234
(100 %)
0 diff
(100 %id)
CD624194   .a 518 to 1245 745 to 19       727/745
(97 %)
1 diff
(99.9 %id)
DN991909 brain, whole brain .a 534 to 1262 1 to 729       729/729
(100 %)
7 diff
(99.1 %id)
BM887905 eye .a 539 to 921 1 to 384       384/384
(100 %)
1 diff
(99.8 %id)
AL523843 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 550 to 1255 296 to 990       695/698
(99 %)
30 diff
(95.8 %id)
BG676460 skin, squamous cell carcinoma .a 556 to 1254 1 to 700       700/700
(100 %)
1 diff
(99.9 %id)
CD624199   .a 604 to 1207 1 to 606       606/606
(100 %)
2 diff
(99.7 %id)
CD624200   .a 604 to 1416 829 to 17       813/829
(98 %)
0 diff
(100 %id)
CN390939 embryonic stem cells, cell lines H1, H7, andH9 .a 606 to 950 1 to 345       345/345
(100 %)
0 diff
(100 %id)
AF125175 heart .a 611 to 2128 1 to 1518 exact     1518/1518
(100 %)
2 diff
(99.9 %id)
TI_1948133449   .a 631 to 1273 123 to 766       644/1336
(48 %)
7 diff
(99.5 %id)
TI_1948133450   .a 631 to 1638 126 to 1140       1015/1412
(71 %)
37 diff
(97.4 %id)
TI_1948133451   .a 631 to 1641 123 to 1130       1008/1319
(76 %)
47 diff
(96.5 %id)
TI_1948133985   .a 631 to 1448 124 to 940       817/1420
(57 %)
27 diff
(98.1 %id)
TI_1948133986   .a 631 to 1742 130 to 1237       1109/1382
(80 %)
51 diff
(96.4 %id)
TI_1948133987   .a 631 to 1641 121 to 1125       1005/1315
(76 %)
32 diff
(97.6 %id)
TI_1948134531   .a 631 to 1557 131 to 1052       922/1341
(68 %)
18 diff
(98.7 %id)
TI_1948134532   .a 631 to 1642 122 to 1143       1022/1318
(77 %)
50 diff
(96.3 %id)
TI_1948135065   .a 631 to 1448 122 to 940       819/1345
(60 %)
27 diff
(98.0 %id)
TI_1948135066   .a 631 to 1632 121 to 1115       995/1373
(72 %)
46 diff
(96.7 %id)
TI_1948135067   .a 631 to 1641 123 to 1129       1007/1319
(76 %)
40 diff
(97.0 %id)
CV023657 mixed .a 632 to 1282 1 to 651       651/651
(100 %)
0 diff
(100 %id)
BQ711105 Spleen .a 720 to 1633 1 to 912       912/929
(98 %)
10 diff
(99.0 %id)
BG913062 anaplastic oligodendroglioma with 1p/19qloss, brain .a 840 to 1285 12 to 461       450/541
(83 %)
9 diff
(98.4 %id)
BP217226 corpus callosum .a 876 to 1455 1 to 581       581/582
(99 %)
7 diff
(98.8 %id)
BF346255 anaplastic oligodendroglioma with 1p/19qloss, brain .a 896 to 1268 1 to 373       373/992
(37 %)
2 diff
(99.8 %id)
BF337643 brain, glioblastoma with EGFR amplification .a 915 to 1273 1 to 359       359/366
(98 %)
1 diff
(99.8 %id)
BQ952353 sciatic nerve .a 927 to 1808 1 to 883       883/884
(99 %)
16 diff
(98.2 %id)
CU454228 epidermis .a 928 to 1270 355 to 13     Submitted on the opposite strand 343/371
(92 %)
0 diff
(100 %id)
N47466 multiple sclerosis lesions .a 951 to 1419 1 to 462       462/462
(100 %)
17 diff
(96.4 %id)
CX871078 embryonic stem .a 977 to 1642 1 to 666       666/666
(100 %)
0 diff
(100 %id)
TI_1948133988   .a 1061 to 2112 1172 to 127       1046/1261
(82 %)
53 diff
(95.8 %id)
BQ695399 adipose .a 1062 to 1443 1 to 383       383/384
(99 %)
4 diff
(99.0 %id)
TI_1948135068   .a 1067 to 2112 1167 to 128       1040/1265
(82 %)
22 diff
(98.3 %id)
TI_1948134533   .a 1109 to 2112 1134 to 129       1006/1273
(79 %)
29 diff
(97.8 %id)
TI_1948133454   .a 1127 to 2112 1114 to 129       986/1152
(85 %)
24 diff
(98.0 %id)
TI_1948134535   .a 1132 to 2112 1104 to 130       975/1141
(85 %)
15 diff
(98.7 %id)
TI_1948135070   .a 1148 to 2112 1096 to 128       969/1154
(83 %)
23 diff
(98.1 %id)
AL702281 human skeletal muscle .a 1156 to 1407 1 to 252       252/252
(100 %)
1 diff
(99.7 %id)
TI_1948134534   .a 1165 to 2112 1064 to 129       936/1218
(76 %)
28 diff
(97.8 %id)
DA944891 Spleen .a 1201 to 1747 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
TI_1948135069   .a 1204 to 2112 1030 to 128       903/1302
(69 %)
17 diff
(98.7 %id)
BG896285 cartilage .a 1206 to 1720 77 to 593       517/525
(98 %)
7 diff
(98.7 %id)
TI_1948133990   .a 1222 to 2112 1027 to 128       900/1198
(75 %)
68 diff
(94.4 %id)
TI_1948133452   .a 1248 to 2112 991 to 127       865/1276
(67 %)
6 diff
(99.6 %id)
CA407471 adipose .a 1260 to 1849 1 to 588       588/588
(100 %)
4 diff
(99.4 %id)
AL527015 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1266 to 2397 1128 to 1   fully sequenced,   1128/1128
(100 %)
26 diff
(97.7 %id)
AL523842 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1273 to 2385 1106 to 1       1106/1126
(98 %)
46 diff
(96.0 %id)
CD515102 White Matter .a 1277 to 1747 1 to 472       472/585
(80 %)
5 diff
(99.2 %id)
AL572386 placenta, Placenta Cot 25-normalized .a 1281 to 2362 1108 to 36       1073/1131
(94 %)
29 diff
(97.5 %id)
TI_1948133453   .a 1281 to 2112 958 to 127       832/1317
(63 %)
15 diff
(98.9 %id)
AK075026 ovary, tumor tissue .a 1330 to 3713 1 to 2384   tiling clone, available from FLJ,   2384/2384
(100 %)
3 diff
(99.9 %id)
DA811957 ovary, tumor tissue .a 1331 to 2079 2 to 747   capped   746/746
(100 %)
8 diff
(99.0 %id)
BE745986 adenocarcinoma cell line, ovary .a 1350 to 2101 1 to 747       747/990
(75 %)
8 diff
(99.2 %id)
AA255590 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1400 to 1485 1 to 86       86/86
(100 %)
0 diff
(100 %id)
AA773234 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1400 to 1850 1 to 449       451/449
(100 %)
3 diff
(99.4 %id)
DA091666 cerebellum .a 1435 to 1992 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
T11442   .a 1449 to 1913 1 to 465       465/465
(100 %)
1 diff
(99.8 %id)
AL525269 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1450 to 2379 930 to 1       930/930
(100 %)
34 diff
(96.4 %id)
BF038385 adenocarcinoma, ovary .a 1457 to 2025 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BE745312 adenocarcinoma cell line, ovary .a 1475 to 2176 1 to 698       698/999
(69 %)
25 diff
(97.5 %id)
DA881536   .a 1502 to 2049 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
TI_154121026   .a 1503 to 2426 994 to 83   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 912/1002
(91 %)
17 diff
(98.4 %id)
BQ650478 hepatocellular carcinoma, cell line, Liver .a 1512 to 2379 1 to 875       875/875
(100 %)
19 diff
(97.9 %id)
CB266196 adipose .a 1518 to 2021 1 to 506       506/506
(100 %)
7 diff
(98.7 %id)
BE700931 nervous_normal .a 1575 to 2019 1 to 443       443/443
(100 %)
7 diff
(98.5 %id)
BX482997   .a 1603 to 2284 1 to 681       681/683
(99 %)
5 diff
(99.3 %id)
DA520203 brain .a 1613 to 2147 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
BX471038   .a 1629 to 1990 1 to 362       362/362
(100 %)
2 diff
(99.5 %id)
CD624190   .a 1640 to 2333 713 to 28       686/725
(94 %)
10 diff
(98.7 %id)
TI_154050166   .a 1640 to 2424 871 to 92   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 780/1050
(74 %)
20 diff
(98.1 %id)
BP345694 synovial membrane .a 1656 to 2236 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BQ717905 sympathetic trunk .a 1690 to 2424 1 to 735   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 735/735
(100 %)
0 diff
(100 %id)
T35448 lung .a 1691 to 1899 1 to 210       210/210
(100 %)
1 diff
(99.6 %id)
BG818196 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1713 to 2592 1 to 872       872/880
(99 %)
38 diff
(95.7 %id)
CD624197   .a 1717 to 2333 652 to 26       627/652
(96 %)
10 diff
(98.5 %id)
CD624192   .a 1724 to 2333 633 to 25       609/633
(96 %)
2 diff
(99.7 %id)
CA411602 Knee, Osteoarthritic Cartilage .a 1731 to 2400 682 to 13   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 670/670
(100 %)
1 diff
(99.9 %id)
BU624314 cell lines, Enchondroma .a 1747 to 2394 667 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 649/649
(100 %)
1 diff
(99.9 %id)
DA384545 thalamus .a 1762 to 2341 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
BQ574556 Chondrosarcoma Grade II, Left Pelvis .a 1767 to 2421 673 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 655/655
(100 %)
0 diff
(100 %id)
CD624196   .a 1789 to 2333 569 to 25       545/569
(95 %)
3 diff
(99.5 %id)
BM999031 lung, Lung Focal Fibrosis .a 1796 to 2424 646 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 628/628
(100 %)
3 diff
(99.6 %id)
BF922090 nervous_tumor .a 1805 to 2016 5 to 218       214/218
(98 %)
6 diff
(97.3 %id)
W77823 heart .a 1806 to 2257 1 to 458       458/458
(100 %)
8 diff
(98.3 %id)
AL702221 human skeletal muscle .a 1809 to 2145 10 to 346       337/346
(97 %)
4 diff
(98.9 %id)
AI074333 senescent fibroblast .a 1853 to 2425 577 to 5       573/577
(99 %)
4 diff
(99.4 %id)
DA978237 synovial membrane tissue from rheumatioidarthritis .a 1853 to 2409 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
AW055104 brain, glioblastoma (pooled) .a 1856 to 2421 566 to 1       566/566
(100 %)
9 diff
(98.5 %id)
AW383343 head_neck .a 1861 to 2278 1 to 416       416/609
(68 %)
13 diff
(97.9 %id)
BE669929 carcinoid, lung .a 1868 to 2425 566 to 9       558/566
(98 %)
1 diff
(99.9 %id)
CK819236 Islets of Langerhans, Pancreas .a 1870 to 2449 1 to 580       580/580
(100 %)
0 diff
(100 %id)
AA320887 adipose tissue, white .a 1880 to 2114 1 to 235       235/235
(100 %)
2 diff
(99.2 %id)
BM128215 Islets of Langerhans, Pancreas .a 1886 to 2438 1 to 553       553/553
(100 %)
0 diff
(100 %id)
AI569207 anaplastic oligodendroglioma, brain .a 1889 to 2413 525 to 1       525/525
(100 %)
1 diff
(99.9 %id)
BG210360   .a 1903 to 2112 43 to 249       207/249
(83 %)
6 diff
(97.6 %id)
DA821227 pericardium .a 1903 to 2477 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
AW006802 colon .a 1914 to 2414 505 to 6       500/505
(99 %)
0 diff
(100 %id)
AI467954 pooled .a 1915 to 2425 516 to 6       511/518
(98 %)
0 diff
(100 %id)
BG191758   .a 1920 to 2424 1 to 504   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 504/504
(100 %)
2 diff
(99.7 %id)
AI738658 colon, colon tumor, RER+ .a 1937 to 2015 79 to 1       79/79
(100 %)
1 diff
(98.8 %id)
AI869652 anaplastic oligodendroglioma, brain .a 1968 to 2410 446 to 3       444/455
(97 %)
0 diff
(100 %id)
AW385297 leiomios .a 1972 to 2340 369 to 2       368/369
(99 %)
0 diff
(100 %id)
BF347729 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1990 to 2423 37 to 472       436/486
(89 %)
5 diff
(99.0 %id)
AI076532 liver and spleen .a 2008 to 2414 413 to 7       407/413
(98 %)
0 diff
(100 %id)
AA255567 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2042 to 2424 383 to 1       383/383
(100 %)
1 diff
(99.8 %id)
AW014997   .a 2052 to 2425 390 to 17       374/390
(95 %)
0 diff
(100 %id)
AW438656 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2088 to 2426 339 to 1       339/339
(100 %)
0 diff
(100 %id)
BE706644 head_neck .a 2091 to 2577 1 to 486       486/486
(100 %)
7 diff
(98.6 %id)
AW855861 colon .a 2095 to 2622 535 to 10       526/643
(81 %)
0 diff
(100 %id)
BE927356 colon .a 2095 to 2622 535 to 10       526/643
(81 %)
0 diff
(100 %id)
AW579946 head_neck .a 2096 to 2628 551 to 20       532/562
(94 %)
0 diff
(100 %id)
BG056922 anaplastic oligodendroglioma, brain .a 2103 to 2413 321 to 11   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 311/311
(100 %)
0 diff
(100 %id)
DA541154 lung .a 2106 to 2690 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
BX391859 Placenta Cot 25-normalized .a 2113 to 2895 787 to 1       787/805
(97 %)
38 diff
(95.3 %id)
AI245368 Kidney .a 2113 to 2413 301 to 1       301/301
(100 %)
0 diff
(100 %id)
BG055795 anaplastic oligodendroglioma, brain .a 2113 to 2425 314 to 2       313/314
(99 %)
0 diff
(100 %id)
BE877692 large cell carcinoma, undifferentiated, lung .a 2117 to 2940 1 to 817       817/1078
(75 %)
38 diff
(96.5 %id)
AA304929 brain, cerebellum .a 2132 to 2429 1 to 299       299/299
(100 %)
1 diff
(99.7 %id)
AW302343 brain, three pooled meningiomas .a 2138 to 2422 285 to 1       285/285
(100 %)
0 diff
(100 %id)
AI242807 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2144 to 2424 281 to 1       281/281
(100 %)
0 diff
(100 %id)
BE763141 nervous_tumor .a 2148 to 2406 88 to 346       259/346
(74 %)
6 diff
(98.3 %id)
AW604517 colon .a 2202 to 2622 625 to 205       421/625
(67 %)
0 diff
(100 %id)
AI419095 brain, glioblastoma (pooled) .a 2209 to 2421 214 to 1       214/214
(100 %)
2 diff
(99.1 %id)
CB215142 normal endometrium, late proliferativephase, cycle day 13, uterus .a 2217 to 2854 1 to 638       638/638
(100 %)
0 diff
(100 %id)
Z45410 brain, total brain .a 2274 to 2601 1 to 328       328/328
(100 %)
2 diff
(99.4 %id)
AF007150 brain .a 2275 to 3719 1 to 1444   tiling clone, AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 1444/1444
(100 %)
1 diff
(100.0 %id)
AW953247   .a 2275 to 2955 11 to 689       679/690
(98 %)
11 diff
(98.5 %id)
R51427 whole brain .a 2275 to 2754 1 to 484     Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 484/485
(99 %)
25 diff
(94.9 %id)
AA350450 brain .a 2276 to 2630 1 to 355       355/355
(100 %)
0 diff
(100 %id)
R51659 whole brain .a 2276 to 2706 1 to 435       435/437
(99 %)
13 diff
(97.1 %id)
AW834698 leiomios .a 2290 to 2916 627 to 1       627/627
(100 %)
11 diff
(98.3 %id)
T77327 whole brain .a 2305 to 2605 1 to 303     Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 303/390
(77 %)
7 diff
(98.3 %id)
AW834705 leiomios .a 2313 to 2914 601 to 1       601/601
(100 %)
8 diff
(98.7 %id)
BF357792 leiomios .a 2381 to 2800 419 to 1       419/419
(100 %)
1 diff
(99.8 %id)
AW385295 leiomios .a 2404 to 2971 568 to 1       568/570
(99 %)
2 diff
(99.7 %id)
AW385315 leiomios .a 2410 to 2938 18 to 545       528/545
(96 %)
6 diff
(98.9 %id)
AW605060 denis_drash .a 2413 to 2916 502 to 1       502/502
(100 %)
4 diff
(99.3 %id)
BF037093 adenocarcinoma, ovary .a 2413 to 3208 1 to 804       804/849
(94 %)
21 diff
(97.6 %id)
AW385288 leiomios .a 2434 to 2967 537 to 4       534/537
(99 %)
0 diff
(100 %id)
FN137760 breast carcinoma .a 2537 to 2627 90 to 1     Submitted on the opposite strand 90/93
(96 %)
3 diff
(96.8 %id)
W73176 heart .a 2548 to 3099 1 to 544       544/547
(99 %)
10 diff
(98.2 %id)
BF747206 breast .a 2562 to 2767 228 to 26     Submitted on the opposite strand 203/228
(89 %)
12 diff
(94.8 %id)
BF747213 breast .a 2566 to 2821 260 to 3     Submitted on the opposite strand 258/260
(99 %)
0 diff
(100 %id)
CN390940 embryonic stem cells, DMSO-treated H9 cellline .a 2579 to 3330 1 to 753       753/753
(100 %)
7 diff
(99.1 %id)
AW385389 leiomios .a 2656 to 3165 516 to 9       508/518
(98 %)
0 diff
(100 %id)
AL577563 placenta, Placenta Cot 25-normalized .a 2661 to 3684 1010 to 1       1010/1010
(100 %)
25 diff
(97.6 %id)
AL546267 placenta, Placenta Cot 25-normalized .a 2665 to 3671 991 to 1       991/995
(99 %)
24 diff
(97.6 %id)
AW385390 leiomios .a 2670 to 3130 466 to 6       461/468
(98 %)
0 diff
(100 %id)
AW839142 leiomios .a 2715 to 3137 432 to 10       423/432
(97 %)
0 diff
(100 %id)
W73148 heart .a 3138 to 3713 569 to 1       569/619
(91 %)
8 diff
(98.8 %id)
DB371226 ovary, tumor tissue .a 3263 to 3713 454 to 1       454/462
(98 %)
9 diff
(98.1 %id)
R51315 whole brain .a 3279 to 3719 464 to 14   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 451/455
(99 %)
17 diff
(96.3 %id)
R38293 whole brain .a 3322 to 3719 417 to 12   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 406/410
(99 %)
12 diff
(97.1 %id)
R51569 whole brain .a 3354 to 3720 381 to 4       378/401
(94 %)
0 diff
(100 %id)
Z41121 brain, total brain .a 3429 to 3719 291 to 1       291/291
(100 %)
0 diff
(100 %id)
R47836 breast .b 1 to 307 1 to 311   tiling clone,   311/311
(100 %)
14 diff
(95.5 %id)
R49978 breast .b 1054 to 1366 317 to 14   tiling clone,   304/317
(95 %)
2 diff
(99.4 %id)
AW298263   .b 1057 to 1366 327 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 310/310
(100 %)
0 diff
(100 %id)
AK074726   .c 1 to 2575 2 to 2576   tiling clone, available from FLJ,   2576/2576
(100 %)
2 diff
(100.0 %id)
DA728466   .c 1 to 669 2 to 669   capped   668/668
(100 %)
1 diff
(99.9 %id)
TI_154039520   .c 1589 to 2585 1086 to 100   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 987/1006
(98 %)
56 diff
(94.5 %id)
AL598843   .c 1608 to 2353 1 to 753       753/754
(99 %)
10 diff
(98.7 %id)
DB282282 uterus .c 1627 to 2167 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
BI016960 lung_tumor .c 1679 to 2089 430 to 23       408/430
(94 %)
0 diff
(100 %id)
TI_154109776   .c 1682 to 2575 975 to 90   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 886/945
(93 %)
18 diff
(98.1 %id)
TI_154121294   .c 1683 to 2585 974 to 88   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 887/1004
(88 %)
32 diff
(96.9 %id)
DT219945 brain .c 1684 to 2317 1 to 634       634/634
(100 %)
0 diff
(100 %id)
BE742066 adenocarcinoma cell line, ovary .c 1690 to 2482 1 to 799       799/1144
(69 %)
27 diff
(97.7 %id)
AW839429 leiomios .c 1696 to 2127 19 to 450       432/450
(96 %)
6 diff
(98.7 %id)
BI035459 nervous_normal .c 1719 to 2172 1 to 454       454/455
(99 %)
3 diff
(99.4 %id)
BE875369 large cell carcinoma, undifferentiated, lung .c 1767 to 2526 1 to 758       758/758
(100 %)
11 diff
(98.6 %id)
TI_149312260   .c 1801 to 2591 869 to 87   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 783/935
(83 %)
10 diff
(99.0 %id)
TI_154103936   .c 1801 to 2585 856 to 80   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 777/944
(82 %)
10 diff
(99.0 %id)
TI_154124644   .c 1801 to 2575 866 to 100   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 767/910
(84 %)
14 diff
(98.5 %id)
CA448013 Chondrosarcoma, Left Pelvis .c 1851 to 2575 743 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 725/725
(100 %)
1 diff
(99.9 %id)
BQ446292 Knee, Osteoarthritic Cartilage .c 1851 to 2585 750 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 732/732
(100 %)
4 diff
(99.5 %id)
BU689594 lung .c 1884 to 2591 722 to 17   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 706/706
(100 %)
3 diff
(99.6 %id)
BQ181797 Knee, Osteoarthritic Cartilage .c 1893 to 2585 711 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 693/693
(100 %)
1 diff
(99.9 %id)
CA415791 Chondrosarcoma Cell line .c 1893 to 2575 699 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 681/681
(100 %)
3 diff
(99.6 %id)
CA446122 Chondrosarcoma, Left Pelvis .c 1903 to 2585 701 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 683/683
(100 %)
1 diff
(99.9 %id)
BQ183929 Knee, Osteoarthritic Cartilage .c 1937 to 2591 669 to 17   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 653/653
(100 %)
4 diff
(99.4 %id)
BQ183356 Knee, Osteoarthritic Cartilage .c 1938 to 2591 670 to 17   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 654/654
(100 %)
2 diff
(99.7 %id)
BQ006002 Chondrosarcoma, Left Pelvis .c 1939 to 2585 664 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 646/646
(100 %)
2 diff
(99.7 %id)
BM990710 lung, Lung Focal Fibrosis .c 1939 to 2581 661 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 643/643
(100 %)
1 diff
(99.9 %id)
BQ181026 Knee, Osteoarthritic Cartilage .c 1951 to 2591 659 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 641/641
(100 %)
1 diff
(99.9 %id)
AA617726 breast .c 1993 to 2585 586 to 1       586/622
(94 %)
22 diff
(96.5 %id)
CK819235 Islets of Langerhans, Pancreas .c 2023 to 2586 572 to 9       564/572
(98 %)
0 diff
(100 %id)
BQ182797 Knee, Osteoarthritic Cartilage .c 2053 to 2589 555 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 537/537
(100 %)
2 diff
(99.7 %id)
BE857139 brain, glioblastoma (pooled) .c 2054 to 2585 532 to 1       532/532
(100 %)
0 diff
(100 %id)
BE858235 brain, glioblastoma (pooled) .c 2054 to 2576 525 to 3       523/525
(99 %)
0 diff
(100 %id)
AI674329 Prostate .c 2055 to 2575 522 to 1       522/522
(100 %)
1 diff
(99.9 %id)
BQ183103 Knee, Osteoarthritic Cartilage .c 2067 to 2585 537 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 519/528
(98 %)
1 diff
(99.9 %id)
FN078614 breast carcinoma .c 2079 to 2160 89 to 1     Submitted on the opposite strand 89/89
(100 %)
5 diff
(94.4 %id)
AI677659 adenocarcinoma, Pancreas .c 2103 to 2586 486 to 3       484/486
(99 %)
0 diff
(100 %id)
AI634890 adenocarcinoma, Pancreas .c 2104 to 2591 488 to 1       488/488
(100 %)
0 diff
(100 %id)
AI081582 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2109 to 2586 478 to 2       477/478
(99 %)
0 diff
(100 %id)
AI160213 brain, glioblastoma (pooled) .c 2121 to 2576 457 to 2       456/457
(99 %)
0 diff
(100 %id)
AI814975 adenocarcinoma, Pancreas .c 2132 to 2576 446 to 1       446/446
(100 %)
1 diff
(99.8 %id)
AI143733 heart .c 2142 to 2585 444 to 1       444/444
(100 %)
0 diff
(100 %id)
AA662773 normal prostate, Prostate .c 2150 to 2585 435 to 1       435/435
(100 %)
1 diff
(99.8 %id)
BX096994 whole brain .c 2160 to 2591 446 to 15   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 432/432
(100 %)
0 diff
(100 %id)
BM127907 Islets of Langerhans, Pancreas .c 2160 to 2586 435 to 9       427/435
(98 %)
0 diff
(100 %id)
AI091081 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2162 to 2590 430 to 2       429/430
(99 %)
0 diff
(100 %id)
AI094459 pooled .c 2165 to 2575 411 to 1       411/411
(100 %)
1 diff
(99.8 %id)
AI377091 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2178 to 2575 412 to 15   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 398/398
(100 %)
0 diff
(100 %id)
AW118246 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 2178 to 2576 404 to 6       399/404
(98 %)
0 diff
(100 %id)
AW130955 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 2179 to 2586 418 to 9       410/418
(98 %)
0 diff
(100 %id)
AI934310 adenocarcinoma, Pancreas .c 2180 to 2575 435 to 40   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 396/396
(100 %)
0 diff
(100 %id)
BE046352 colon, juvenile granulosa tumor .c 2180 to 2575 410 to 15   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 396/396
(100 %)
1 diff
(99.8 %id)
AI079989 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2184 to 2592 415 to 7       409/415
(98 %)
0 diff
(100 %id)
AJ346671 pectoral muscle (after mastectomy) .c 2185 to 2575 1 to 390       390/390
(100 %)
7 diff
(98.3 %id)
AA513430 breast .c 2200 to 2585 405 to 21   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 385/385
(100 %)
1 diff
(99.8 %id)
BQ183220 Knee, Osteoarthritic Cartilage .c 2206 to 2575 388 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 370/370
(100 %)
4 diff
(99.0 %id)
AI690607 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 2210 to 2575 382 to 15   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 368/368
(100 %)
3 diff
(99.2 %id)
AI625691 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 2211 to 2575 365 to 1       365/365
(100 %)
0 diff
(100 %id)
AI097513 heart .c 2214 to 2576 371 to 9       363/371
(97 %)
0 diff
(100 %id)
AW073499 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .c 2217 to 2576 389 to 30       360/389
(92 %)
0 diff
(100 %id)
AW009810 colon .c 2222 to 2576 358 to 4       355/358
(99 %)
0 diff
(100 %id)
AI129887 uterus .c 2224 to 2592 375 to 7       369/376
(98 %)
0 diff
(100 %id)
BG056067 anaplastic oligodendroglioma, brain .c 2226 to 2576 354 to 3       352/354
(99 %)
0 diff
(100 %id)
AI189337 uterus .c 2233 to 2592 368 to 9   tiling clone,   360/368
(97 %)
0 diff
(100 %id)
AA722380 heart .c 2236 to 2585 372 to 23   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 350/350
(100 %)
1 diff
(99.8 %id)
AA704833 liver and spleen .c 2237 to 2589 353 to 1       353/353
(100 %)
2 diff
(99.5 %id)
AA502111 liposarcoma .c 2237 to 2590 367 to 14       354/367
(96 %)
0 diff
(100 %id)
AI033220 liver and spleen .c 2238 to 2589 351 to 1       351/351
(100 %)
2 diff
(99.5 %id)
T33401 brain .c 2250 to 2591 343 to 1       343/343
(100 %)
4 diff
(98.9 %id)
AA193294 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2256 to 2528 1 to 273       273/278
(98 %)
3 diff
(99.0 %id)
BG954774 colon .c 2275 to 2450 176 to 1       176/176
(100 %)
6 diff
(96.6 %id)
BG057110 anaplastic oligodendroglioma, brain .c 2283 to 2576 318 to 25       294/318
(92 %)
0 diff
(100 %id)
BM055277 Islets of Langerhans, Pancreas .c 2306 to 2592 1 to 287   fully sequenced,   287/287
(100 %)
2 diff
(99.4 %id)
AI669103 Prostate .c 2363 to 2576 219 to 6       214/219
(97 %)
0 diff
(100 %id)
AI140165 heart .c 2366 to 2585 220 to 1       220/220
(100 %)
7 diff
(96.9 %id)
FN128905 breast carcinoma .c 2386 to 2462 1 to 76       76/81
(93 %)
3 diff
(96.3 %id)
AI352063 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2390 to 2586 198 to 2       197/198
(99 %)
0 diff
(100 %id)
AA424013   .c 2419 to 2586 172 to 5       168/172
(97 %)
0 diff
(100 %id)
BM055005 Islets of Langerhans, Pancreas .c 2451 to 2592 142 to 1   fully sequenced,   142/142
(100 %)
0 diff
(100 %id)
AK054861 cerebellum .d-u 1 to 2226 2 to 2227 exact tiling clone, available from FLJ,   2227/2227
(100 %)
1 diff
(100.0 %id)
DA056836 cerebellum .d-u 1 to 611 2 to 612   capped   611/612
(99 %)
2 diff
(99.7 %id)
DB296648 cerebellum .d-u 1680 to 2226 548 to 1       548/548
(100 %)
1 diff
(99.9 %id)
AK307175   Gene ANGPTL2, variant not shown         Suspected internal deletion, this clone was ignored    
DA231963 brain Gene ANGPTL2, variant not shown       capped      
DB305838 brain Gene ANGPTL2, variant not shown              
DA239127 brain Gene ANGPTL2, variant not shown       capped      
AL598484   Gene ANGPTL2, variant not shown         Suspected internal deletion, this clone was ignored    
AI373732 Kidney Gene ANGPTL2, variant not shown         Suspected internal deletion, this clone was ignored    
BF033990 adenocarcinoma, ovary Gene ANGPTL2, variant not shown         Suspected internal deletion, this clone was ignored    
TI_154130793   Gene ANGPTL2, variant not shown       AAA This clone was ignored    
BQ446126 Knee, Osteoarthritic Cartilage Gene ANGPTL2, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C